GFAT1 Antibodies

Santa Cruz Biotechnology delivers a wide array of GFAT1 monoclonal antibodies for research focused on understanding GFAT1's role in cellular metabolism. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GFAT1, or Glutamine-Fructose-6-Phosphate Transaminase 1, functions as a key enzyme in the hexosamine biosynthetic pathway, which is essential for glycoprotein and glycolipid synthesis. GFAT1 plays a significant role in regulating cellular responses to nutrient availability and stress, maintaining cellular homeostasis. Research has shown that GFAT1 dysregulation is linked to various metabolic disorders and diseases. Scientists can investigate GFAT1's cellular distribution, protein interactions, and expression patterns using specific detection methods. Researchers can examine GFAT1's involvement in different physiological and pathological conditions through multiple experimental approaches. Understanding GFAT1's mechanisms can provide insights into potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of GFAT1's role in health and disease.